Optipharm.CO.,LTD
Research Optipharm.CO.,LTD (153710.KQ) on Bullrun: market cap KRW 65.06B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker153710.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyKRW
- Market capKRW 65.06B
- Financial periodQ2 2026
- RevenueKRW 6.59B
- Net income-KRW 216.94M
- Free cash flowKRW 774.62M
- Gross margin25.6%
Valuation Snapshot
latest market cap is KRW 65.06B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 65.06B | n/a | n/a | n/a |
Dividend history
About Optipharm.CO.,LTD
Optipharm.CO.,LTD operates as a biomedical solution provider in South Korea. It also engages in animal disease diagnosis, animal medicine, bacteriophage, Medipig, xenogenic organs, VLP vaccines, xenotransplantation, and other optipharm products, as well as veterinary drug for feed additives and laboratory animal Medipig business. The company was formerly known as Optiparm Solution Co., Ltd. and changed its name to Optipharm.CO.,LTD in 2012.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Optipharm.CO.,LTD's market cap?
Optipharm.CO.,LTD's market capitalization is KRW 65.06B.
What does Optipharm.CO.,LTD do?
Optipharm.CO.,LTD operates as a biomedical solution provider in South Korea. It also engages in animal disease diagnosis, animal medicine, bacteriophage, Medipig, xenogenic organs, VLP vaccines, xenotransplantation, and other optipharm products, as well as veterinary drug for feed additives and laboratory animal Medipig business. The company was formerly known as Optiparm Solution Co., Ltd. and changed its name to Optipharm.CO.,LTD in 2012. Optipharm.CO.,LTD was founded in 2000 and is based in Cheongju, South Korea.